Breast cancer and the western diet: Role of fatty acids and antioxidant vitamins

European Journal of Cancer

Volumn 34, Issue 12, 1998, Pages 1852-1856

  Stoll, B A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antioxidants; Breast cancer; Fatty acidss; Hyperinsulinaemia; Insulin like growth factor; Vitamin A; Vitamin E; Western diet

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; INSULIN; POLYUNSATURATED FATTY ACID; RETINOL; VITAMIN;

ANTIOXIDANT ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; DIET SUPPLEMENTATION; DIETARY INTAKE; FAT INTAKE; FEMALE; HUMAN; HYPERINSULINEMIA; PRIORITY JOURNAL; REVIEW; WESTERN HEMISPHERE;

ANIMALS; ANTIOXIDANTS; BREAST NEOPLASMS; DIET; FATTY ACIDS; FEMALE; HUMANS; RATS; VITAMINS;

EID: 0032213458     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00204-4     Document Type: Review

References (81)

1. 1. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer 1975, 15, 617-621.
2. 2. Willett WC. Cancer prevention; diet and risk reduction. In De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott-Raven, 1997, 559-565.
3. 3. Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer; combined analysis of 12 case control studies. J Natl Cancer Inst 1990, 82, 561-569.
4. 4. Willett WC, Hunter DJ, Stampfer MJ, et al. Dietary fat and fiber in relation to risk of breast cancer, an 8-year follow up. JAMA 1992, 268, 2037-2041.
5. 5. Ip C, Marshall JR. Trans fatty acids and cancer. Nutr Rev 1996, 54, 138-145.
6. 6. Braden LM, Carroll KK. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids 1986, 21, 285-288.
7. 7. Welsch CW. Enhancement of mammary tumorigenesis by dietary fat; review of potential mechanisms. Am J Clin Nutr 1987, 45, 192-202.
8. 8. Chajes V, Lhuillery C, Sattler W, et al. Alpha-tocopherol and hydroperoxide content in breast adipose tissue from patients with breast tumors. Int J Cancer 1996, 67, 170-175.
9. 9. Rose DP, Connolly JM, Coleman M. Effect of n-3 fatty acids on the progression of metastases after excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res 1996, 2, 1751-1756.
10. 10. Bagga D, Capone S, Wang HJ, et al. Dietary modulation of n-3/ n-6 polyunsaturated fatty acid ratios in patients with breast cancer. Natl Cancer Inst 1997, 89, 1123-1131.
11. 11. Yam D, Eliraz A, Berry EM. Diet and disease; the Israeli paradox. Possible dangers of a high n-6 polyunsaturated fatty acid diet. Israel J Med Sci 1996, 32, 1134-1143.
12. 12. Kaizer L, Boyd NF, Kriukov V, Tritchler D. Fish consumption and breast cancer risk; ecological study. Nutr Cancer 1989, 12, 61-68.
13. 13. Hursting SD, Thornquist M, Henderson MM. Types of dietary fat and the incidence of cancer at five sites. Prev Med 1990, 19, 242-253.
14. 14. Caygill CPJ, Charlett A, Hill MJ. Fat, fish oil and cancer. Br J Cancer 1996, 74, 159-164.
15. 15. Carroll KK. Dietary fats and cancer. Am J Clin Nutr 1991, 53(Suppl.), 1064-1067.
16. 16. Rose DP, Hatala MA, Connolly JM, Rayburn J. Effects of diet containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res 1993, 53, 4686-4689.
17. 17. Rose DP, Connolly JM. Effects of dietary n-3 fatty acids on human breast cancer growth and metastasis in nude mice. J Natl Cancer Inst 1993, 85, 1743-1746.
18. 18. Thompson LU, Seidl MM, Richard SE, et al. Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 1996, 26, 159-165.
19. 19. Harris WS. n-3 fatty acids and serum lipoproteins; human studies. Am J Clin Nutr 1997, 65(Suppl.), 1645-1654.
20. 20. Schaefer EJ. Effects of dietary fatty acids on lipoproteins and cardiovascular disease risk; a summary. Am J Clin Nutr 1997, 65(Suppl.), 1655-1656.
21. 21. Noguchi M, Rose DP, Earashi M, Miyazaki I. The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. Oncology 1995, 52, 265-271.
22. 22. Marnett LJ. Generation of mutagens during arachidonic acid metabolism. Cancer Metastasis Rev 1994, 13, 303-308.
23. 23. Planchon P, Weber N, Magnien V, et al. Alteration of prostaglandin E receptors in advanced breast tumor cell lines. Mol Cell Endocrinol 1995, 111, 219-223.
24. 24. Egan KM, Stampfer MJ, Giovannucci E, et al. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 1996, 88, 988-993.
25. 25. Schrey MP, Patel KV. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts; regulation by inflammatory mediators. Br J Cancer 1995, 72, 1412-1419.
26. 26. James MJ, Gibson RA, D'Angelo M, et al. Simple relationships exist between dietary linoleate and the n-6 fatty acids of human neutrophils and plasma. Am J Clin Nutr 1993, 58, 497-500.
27. 27. Rose DP. Effects of dietary fatty acids on breast and prostate cancers; evidence from in vitro experiments and animal studies. Am J Clin Nutr 1997, 66(Suppl.), 1513-1522.
28. 28. Aylsworth CF, Cullum ME, Zile MH, Welsch CW. Influence of dietary retinyl acetate on enhancement of DMBA-induced rat mammary carcinogenesis by high levels of dietary fat. J Natl Cancer Inst 1986, 76, 339-345.
29. 29. Ip C. Dietary vitamin E intake and mammary carcinogenesis in rats. Carcinogenesis 1982, 3, 1453-1456.
30. 30. Van't Veer P, Strain JJ, Fernandez-Crehuet J, et al. Tissue antioxidants and postmenopausal breast cancer; the European Community Multicentre Study on antioxidants, myocardial infarction and cancer of the breast (EURAMIC). Cancer Epidemiol Biomarkers Prev 1996, 5, 441-447.
31. 31. Clavel-Chapelon F, Niravong M, Joseph RR. Diet and breast cancer, review of the epidemiologic literature. Cancer Detect Prev 1997, 21, 426-440.
32. 32. Holmes MD, Hunter DJ, Willett WC. Dietary guidelines. In Stoll BA, ed. Reducing Breast Cancer Risk in Women. Dordrecht, Kluwer Academic, 1995, 135-144.
33. 33. Moon RC. Vitamin A, retinoids and breast cancer. Adv Exper Med Biol 1994, 364, 101-107.
34. 34. Torrisi R, Pensa F, Orengo MA, et al. The synthetic retinoid fenretinide lowers IGF1 levels in breast cancer patients. Cancer Res 1993, 53, 4769-4771.
35. 35. Welsch CW, De Hoog JV, Scieszka KM, Aylsworth CF. Retinoid feeding, hormone inhibition and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma. Cancer Res 1984, 44, 166-171.
36. 36. Kimmick GG, Bell RA, Bostick CM. Vitamin E and breast cancer. Nutr Cancer 1997, 27, 109-117.
37. 37. Knekt P. Serum vitamin E level and risk of female cancers. Int J Epidemiol 1988, 17, 281-286.
38. 38. Comstock GH, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer. Am J Clin Nutr 1994, 53, 260s-264s.
39. 39. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension and cardiovascular disease; role for oxidative stress. Metabolism. Clin Exp 1995, 44, 363-368.
40. 40. Weber P, Bendich A, Machlin LJ. Vitamin E and human health rationale for determining recommended intake levels. Nutrition 1997, 13, 450-460.
41. 41. Suarez A, Ramirez MC, Gill A, Faus MJ. Dietary supplementation with long chain PUFAs of n-3 and n-6 series and with vitamin E on the plasma, fatty acid profile. Nutr Hosp 1994, 9, 170-180.
42. 42. Ascherio A, Willett WC. New directions in dietary studies of coronary heart disease. J Nutr 1995, 125, 647s-655s.
43. 43. Verhoeven DTH, Assen N, Goldbohm RA, et al. Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk; a prospective cohort study. Br J Cancer 1997, 75, 149-155.
44. 44. Storlien LH, Pan DA, Kriketos AD, et al. Skeletal muscle membrane lipids and insulin resistance. Lipids 1996, 31(Supp.), 261-265.
45. 45. Gordge PC, Hulme MJ, Clegg RA, Miller WR. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 1996, 32, 2120-2126.
46. 46. Uchida N, Okamura S, Nagamachi Y, Yamashita S. Increased phospholipase D activity in human breast cancer. J Cancer Res Clin Oncol 1997, 123, 280-285.
47. 47. Hahnel R, Geschwendt M. The interaction between protein kinase C and estrogens. Int J Oncol 1995, 7, 11-16.
48. 48. Ways DK, Kukoly CA, Devente J, et al. MCF7 breast cancer cells transfected with PKC alpha exhibit altered expression of other PKC isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 1995, 95, 1906-1915.
49. 49. Kellerer M, Haring HU. Pathogenesis of insulin resistance; modulation of the insulin signal at receptor level. Diab Res Clin Practice 1995, 28(Suppl.), 173-177.
50. 50. Devente JE, Carey JO, Bryant WO, et al. Transcriptional regulation of insulin-receptor substrate 1 by PKC. J Biol Chem 1996, 271, 32276-32280.
51. 51. Agostoni C, Riva E, Bellu R, et al. Relationships between the fatty acid status and insulinemic indexes in obese children. Prostaglandins, Leukotrienes, Essential Fatty Acids 1994, 51, 317-321.
52. 52. Decsi T, Molnar D, Koletzko B. Long chain polyunsaturated fatty acids in plasma lipids of obese children. Lipids 1996, 31, 305-311.
53. 53. Bruning PF, Bonfrer JMG, Van Noord PAH, Hart AAM, De Jong Bakker M, Nooijen WJ. Insulin resistance and breast cancer risk. Int J Cancer 1992, 52, 511-516.
54. 54. Tekden M, Kahraman H, Yucel I, et al. Insulin and C-peptide response to oral glucose in patients with breast cancer. Ann Oncol 1996, 7(Suppl. 5), 24.
55. 55. Muti P, Liu J, Trevison A, Menotti A. Insulin resistance as a risk factor for colon and breast cancer. Am J Epidemiol 1997, 145(Suppl. 11), 25.
56. 56. Gamayunova VB, Bobrov YF, Tsyrlina EV, et al. Comparative study of blood insulin levels in breast and endometrial cancer. Neoplasma 1997, 44, 123-126.
57. 57. Weiderpass E, Gridley G, Persson I, et al. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 1997, 71, 360-363.
58. 58. Westley BR, May FE. Role of IGF in steroid-modulated proliferation. J Ster Biochem Mol Biol 1994, 51, 1-9.
59. 59. Bruning PF, Van Doorn J, Bonfrer JMG, et al. IGFBP3 is decreased in early stage operable premenopausal breast cancer. Int J Cancer 1995, 62, 266-270.
60. 60. Hankinson S, Pollak M, Michaud D, et al. A prospective assessment of plasma IGF levels and breast cancer risk. Am J Epidemiol 1997, 145(Suppl. 11), Abst. 286.
61. 61. Giudice LC. The insulin-like growth factor system in normal and abnormal human ovarian follicle development. Am J Med 1995, 98(Suppl.), 48-54.
62. 62. Fontana JA, Burrows-Mezu A, Clemmons DR, LeRaith D. Retinoid modulation of IGFBP and inhibition of breast carcinoma proliferation. Endocrinology 1991, 128, 1115-1122.
63. 63. Bentel JM, Lebwohl DE, Cullen KJ, et al. IGF modulates the growth inhibitory effects of retinoic acid on MCF7 breast cancer cells. J Cell Physiol 1995, 165, 212-221
64. 64. Adamo ML, Shao ZM, Lanau F, et al. IGF1 and retinoic acid modulation of IGFBP gene expression and protein secretion in a breast cancer cell line. Endocrinology 1992, 131, 1858-1866.
65. 65. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. IGFBP3 mediates retinoic acid and TGF beta 2-induced growth inhibition in human breast cancer cells. Cancer Res 1996, 56, 1545-1550.
66. 66. Rechler MM. Editorial growth inhibition by IGFBP3; what's IGF got to do with it? Endocrinology 1997, 38, 2645-2647.
67. 67. Peyrat JP, Vanlemens L, Fournier J, et al. Prognostic value of urokinase-type plasminogen activator in node-negative breast cancers. Clin Cancer Res 1998, 4, 189-194.
68. 68. De Pergola G, De Mitrio V, Perricci A, et al. Influence of free testosterone on antigen levels of PAI 1 in premenopausal women with central obesity. Metabolism 1992, 41, 131-134.
69. 69. Alessi MC, Peiretti F, Morange P, et al. Production of PAI 1 by human adipose tissue; possible link between visceral fat accumulation and vascular disease. Diabetes 1997, 46, 860-867.
70. 70. Oosthuizen W, Vorster HH, Jerling JC, et al. Both fish oil and olive oil lower plasma fibrinogen in women with high baseline fibrinogen levels. Thrombosis Haemostasis 1994, 72, 557-562.
71. 71. Smith U. Carbohydrates, fat and insulin action. Am J Clin Nutr 1994, 59(Suppl. 3), 686-689.
72. 72. Garland M, Sacks FM, Colditz GA, et al. The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr 1998, 67, 25-30.
73. 73. London SJ, Sacks FM, Caesar J, et al. Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr 1991, 54, 340-345.
74. 74. Kohlmeier L. Biomarkers of fatty acid exposure and breast cancer risk. Am J Clin Nutr 1997, 66(Suppl.), 1548-1556.
75. 75. Simonsen N, van't Veer P, Strain JJ, et al. Adipose tissue n-3 and n-6 fatty acid content and breast cancer in the EURAMIC study. Am J Epidemiol 1998, 147, 342-352.
76. 76. Chajes V, Lanson M, Fetissof F, et al. Membrane fatty acids of breast carcinoma; contribution of host fatty acids and tumor properties. Int J Cancer 1995, 63, 169-175.
77. 77. Sakai K, Okuyama H, Yura J, et al. Composition and turnover of phospholipids and neutral lipids in human breast cancer and reference tissues. Carcinogenesis 1992, 13, 579-584.
78. 78. Hietanen E, Punnonen K, Auvinen O. Fatty acid composition of phospholipids and neutral lipids and lipid peroxidation in human breast cancer and lipoma tissue. Carcinogenesis 1986, 7, 1965-1969.
79. 79. Zhu ZR, Parviainen M, Mannisto S, et al. Vitamin E concentration in breast adipose tissue of breast cancer patients. Cancer Causes Control 1996, 7, 591-595.
80. 80. Gerber M, Astre C, Segala C, et al. Tumor progression and oxidant-antioxidant status. Cancer Lett 1997, 114, 211-214.
81. 81. Saintot M, Astre C, Pujol H, Gerber M. Tumor progression and oxidant-antioxidant status. Carcinogenesis 1996, 17, 1267-1271.